The study progress and second-line chemotherapy of small cell lung cancer
- VernacularTitle:小细胞肺癌的二线化疗及研究进展
- Author:
Lanfang LI
;
Huaqing WANG
- Publication Type:Journal Article
- Keywords:
Second-line chemotherapy;
Small cell lung cancer
- From:
Cancer Research and Clinic
2000;0(06):-
- CountryChina
- Language:Chinese
-
Abstract:
Small cell lung cancer(SCLC) is an chemosensitive and radiosensitive malignant tumor which can appear hematogenous metastasis in early stage. The treatment of SCLC is based on chemotherapy and combined with radiotherapy and operation. In spite of the high response rate, the median time from drug-resistance to death of extensive SCLC is still disappointed. As to limited SCLC, there are still 75 % ~ 80 % patients relapse after inductive chemotherapy and radiotherapy. All in all, the second-line therapy is very important in SCLC patients.
